Insider buying last 90 days
No open-market insider purchases were filed for THC in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every THC insider filing, plotted on the chart in Gekko.Open THC in Gekko
NYSE: THC
Tenet Healthcare (THC) Stock Analysis & Forecast
Sep 28 close
$257.93−1.78 (−0.7%)
Gekko Brief
AI summaryTenet Healthcare's week centers on a $2.0 billion debt refinancing, with new 6.250% senior notes due 2034 issued to redeem existing 5.125% notes due 2027 and partially retire 6.125% notes due 2028, a move framed as extending maturities and enhancing financial flexibility. Alongside this, BMO Capital initiated coverage with a Market Perform rating and a $265.00 price target, while commentary has also focused on whether THC can sustain growth despite softer surgical volumes, with revenue supported by higher revenue per case, acuity, and service mix.
THC closed at $257.93, down 0.7%, trading above both its 50-day average of $256.92 and 200-day average of $212.31, with the shorter average above the longer one. The GekkoIndex reads 58.5, placing the stock in the Neutral zone. Price sits 9.4% below Gekko Fair Value of $284.64.
Tenet's next earnings report is scheduled for 27 October 2026, 28 days out, falling inside a typical 20-trading-day holding window. Options activity over the past 30 days shows 2 unusual signals, with call premium of $453,600 against put premium of $522,680. Seasonality data over 5 years shows the next 20 trading days from this point averaging -8.8%, with gains in 2 of those years. Analyst consensus stands at 16 buy and 2 hold ratings among 18 firms, with a consensus target of $284.64.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Tenet Healthcare price vs fair value
Close $257.93200-day averageGekko Fair Value $284.64
Tenet Healthcare quick facts
- Market cap
- $20.77B
- P/E ratio
- 10
- Forward P/E
- 12.5
- EPS, TTM
- $25.88
- Revenue, TTM
- $21.81B
- Profit margin
- 10.3%
- Dividend yield
- —
- Beta
- 1.23
- Volume
- 541,460 avg 820,138
- 1-year return
- +31.1%
- Typical daily move
- ±3.2%
- Typical 20-day move
- ±8.5%
- 50-day average
- $256.92
- 200-day average
- $212.31
- Next earnings
- Oct 27
- Shares outstanding
- 80.52M
Tenet Healthcare swing-trade checklist
Tenet Healthcare scores 2 supportive, 1 mixed and 3 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed3 headwinds
- Trendsupportive
Above 50 and 200-day
Close $257.93 is above the 50-day ($256.92) and 200-day ($212.31) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
58.5, Neutral
Reading 58.5 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
9.4% below
Price is 9.4% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyheadwind
Leans bearish
Last 30 days: 2 unusual options signals.
See smart money - Earnings riskheadwind
Reports in 28 days
Reports on Oct 27, 2026, 28 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−8.8% on average
From this point in the calendar, the next 20 trading days averaged −8.8% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Tenet Healthcare stock chart and price history
Tenet Healthcare closed at $257.93 on Sep 28, 2026, +31.1% over the past year, inside a 52-week range of $157.58 to $283.05.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −3.7%
- 3 months
- +37.8%
- 6 months
- +34.4%
- 1 year
- +31.1%
The full THC chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open THC in Gekko
Follow Tenet Healthcare through every session
Put THC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track THC in GekkoFree for 7 days. No credit card required.
About Tenet Healthcare
Tenet Healthcare provides a wide range of medical services through hospitals and related clinical sites. Its acute care facilities cover core hospital functions such as surgery and recovery, radiology, respiratory therapy, laboratory work, and pharmacy services, along with intensive and coronary care units. The company also handles specialized treatment in areas like cardiovascular care, digestive disease, neurosciences, musculoskeletal conditions, and obstetrics, extending into advanced procedures including cardiothoracic and neurosurgery, organ transplants, trauma care, stroke treatment, and telemedicine.
Tenet organizes its work into three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Ambulatory Care side runs outpatient surgical centers, urgent care sites, imaging centers, and micro-hospitals, while Conifer supplies business process support to hospitals, health systems, physician practices, and employers, covering revenue cycle management, patient communication, and care outcome services.
Tenet Healthcare was founded in 1975 and is headquartered in Dallas, Texas. Its shares are listed on the NYSE under the ticker THC.
- Listed
- NYSE
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Website
- tenethealth.com
Tenet Healthcare GekkoIndex: the smart money zone
Tenet Healthcare’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 58.5, in the Neutral zone, up 0.5 points over five sessions.
58.5Neutral
Up 0.5 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 28 | +2.5% | +10.9% | ||
| Accumulation | 169 | +1.1% | +5.4% | ||
| Neutral (current zone) | 417 | +1.0% | +2.9% | ||
| Distribution | 55 | +0.2% | +6.4% | ||
| Selling | 3 | Too few readings yet | |||
Average THC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the THC price, zone by zone.Track THC in Gekko
Is Tenet Healthcare stock overvalued? Gekko Fair Value
Tenet Healthcare trades 9.4% below Gekko Fair Value of $284.64, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Tenet Healthcare shares are worth, recalculated every trading day.
$284.64
Gekko Fair Value, Sep 26, 2026
9.4% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open THC in Gekko
Tenet Healthcare insider and Congress trading
No open-market insider purchases were filed for Tenet Healthcare, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in THC were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for THC, plotted on the chart in Gekko.Open THC in Gekko
Buybacks
Tenet Healthcare has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $1.04B
- As a share of market cap
- 5.02%
- Trailing four quarters
- $1.66B
From company filings.
Unusual options activity last 30 days
2signals, 46% of the flagged premium in calls.
Latest: Bullish flow on Sep 19, $454K in unusual premium.
Hedge funds and billionaires quarter ended Jun 30
1of the funds Gekko tracks holds THC.
1added0opened0trimmed2sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko
Tenet Healthcare earnings: next date and track record
Tenet Healthcare reports on Oct 27, 2026 (28 days away), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Oct 27, 2026
28 days away
- EPS estimate
- $4.67
- Revenue estimate
- $5.49B
8 of 8reports beat the EPS estimate
±9.4%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Apr 30, 2026 AI summary
- What they said
- Tenet Healthcare reported Q1 2026 net operating revenues of $5.4 billion and consolidated adjusted EBITDA of $1.16 billion (21.6% margin), exceeding prior expectations. USPI generated $484 million in adjusted EBITDA, up 6% YoY, with same-facility revenues growing 5.3%. Hospital segment EBITDA of $678 million achieved 16.7% margins despite 10% decline in exchange admissions. THC deployed $125 million acquiring 7 ASCs and launched 3 de novo centers, completing half of targeted full-year M&A spend.
- Guidance
- USPI's Q1 result represents 22% of full year 2026 adjusted EBITDA guidance; Hospital segment Q1 represents 27.5% of full year target. Management maintains confidence in managing exchange enrollment headwinds across multiple scenarios while continuing expense initiatives.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Apr 30, 2026 | $4.82 est $4.17 | $5.37B est $5.39B | +1.8% |
| Feb 11, 2026 | $4.70 est $4.07 | $5.53B est $5.47B | +20.3% |
| Oct 28, 2025 | $3.70 est $3.34 | $5.29B est $5.26B | −3.3% |
| Jul 22, 2025 | $4.02 est $2.87 | $5.27B est $5.16B | −9.4% |
| Apr 29, 2025 | $4.36 est $3.13 | $5.22B est $5.14B | +15.4% |
| Feb 12, 2025 | $3.44 est $2.83 | $5.07B est $5.17B | −3.8% |
| Oct 29, 2024 | $2.93 est $2.37 | $5.12B est $5.05B | +13.3% |
| Jul 24, 2024 | $2.31 est $1.90 | $5.10B est $4.99B | +8.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Tenet Healthcare stock forecast and analyst price targets
Analysts’ average 12-month price target for Tenet Healthcare is $284.64, +10.4% from the last close, from 18 firms rating the stock in the last 90 days.
$284.64consensus 12-month target, +10.4% from the last close
Now $257.93Avg $284.64
Low $245High $315
Each firm’s latest rating in the last 90 days: 18 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 28 | Raymond James | $285 | +10.5% |
| Sep 22 | BMO Capital | $265 | +2.7% |
| Sep 17 | Leerink Partners | — | — |
| Sep 14 | Morgan Stanley | $274 | +6.2% |
| Sep 1 | J.P. Morgan | $315 | +22.1% |
+2.9%average 20-day move after past Neutral readings
−8.8%average move over the next 20 trading days in the last 5 years
±3.2%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Tenet Healthcare seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Tenet Healthcare averaged −8.8% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −3.0% | 1 of 5 |
| Next 10 trading days | −7.4% | 1 of 5 |
| Next 15 trading days | −3.7% | 3 of 5 |
| Next 20 trading days | −8.8% | 2 of 5 |
| Next 30 trading days | −4.8% | 2 of 5 |
For scale, THC’s typical 20-trading-day move in either direction is about 8.5%.
Tenet Healthcare market cap and key statistics
Tenet Healthcare’s market cap is $20.77B, with a P/E ratio of 10 and revenue of $21.81B over the last twelve months.
Valuation
- Market cap
- $20.77B
- P/E ratio
- 10
- Forward P/E
- 12.5
- EPS, TTM
- $25.88
- Gekko Fair Value
- $284.64
Trading
- Volume
- 541,460
- Avg volume, 20 days
- 820,138
- 52-week high
- $283.05
- 52-week low
- $157.58
- Shares outstanding
- 80.52M
Financials
- Revenue, TTM
- $21.81B
- Profit margin
- 10.3%
- Return on equity
- 37.3%
- Quarterly earnings growth, YoY
- +213.4%
Risk and income
- Beta
- 1.23
- Typical daily move
- ±3.2%
- Typical 20-day move
- ±8.5%
Tenet Healthcare stock news this week
Coverage of Tenet Healthcare this week reads positive: 4 positive, 3 neutral and 0 negative headlines.
- Is Tenet Healthcare (THC) Outperforming Other Medical Stocks This Year?Zacks Investment Research, Sep 28
- Tenet Healthcare (THC) Refinances $2.0b Of Debt, Is The Stock Still Cheap?Simply Wall Street, Sep 25
- Can Tenet Healthcare Sustain Growth Despite Lower Surgical Volumes?Zacks Investment Research, Sep 24
- Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research, Sep 24
- Tenet Healthcare Price Target Announced at $265.00/Share by BMO CapitalMoomoo, Sep 23
- Tenet Healthcare (THC) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research, Sep 23
Tenet Healthcare peers
Tenet Healthcare’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| HCAHCA Healthcare | Neutral | 12.8% above |
| UHSUniversal Health Services | Neutral | 20.1% below |
| PACSPACS | Accumulation | 14.2% below |
| CHEChemed | Neutral | 5.5% below |
| NHCNational HealthCare | Neutral | 29.0% above |
| BKDBrookdale Senior Living | Buying | 11.8% below |
A peer links to its own page where one exists.
Tenet Healthcare stock FAQ
What is Tenet Healthcare’s market cap?
Tenet Healthcare’s market cap is $20.77B at the Sep 28, 2026 close of $257.93, with 80.52M shares outstanding. The shares trade on a P/E ratio of 10.
What is the Tenet Healthcare stock forecast?
The consensus analyst 12-month price target for Tenet Healthcare is $284.64, +10.4% from the last close. Of the 18 firms that rated the stock in the last 90 days, 16 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Tenet Healthcare stock overvalued or undervalued?
On Gekko’s estimate Tenet Healthcare is undervalued: the Sep 28, 2026 close of $257.93 is 9.4% below Gekko Fair Value of $284.64. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Tenet Healthcare report earnings next?
Tenet Healthcare is expected to report on Oct 27, 2026 (28 days away). Analysts expect earnings of $4.67 per share on revenue of $5.49B. Tenet Healthcare beat the earnings estimate in 8 of its last 8 reports, moving 9.4% on average across the report.
What is Tenet Healthcare’s 52-week high and low?
Tenet Healthcare’s 52-week high is $283.05 and its 52-week low is $157.58; it closed at $257.93 on Sep 28, 2026, +31.1% over the past year.
Is Tenet Healthcare stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 6 items with data read as supportive (trend and fair value), 1 as mixed (gekkoindex) and 3 as headwinds (smart money, earnings risk and seasonality). The checklist is a description of current data, not a recommendation.
Is there unusual options activity in Tenet Healthcare?
Gekko flagged 2 unusual options signals in Tenet Healthcare over the last 30 days, with $454K of flagged premium in calls and $523K in puts. The latest, bullish flow, was on Sep 19, 2026 with $454K in unusual premium. The signal-by-signal table is in Gekko.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Tenet Healthcare the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.